Interpretable multimodal network analysis of lipid‐lowering therapies
British Journal of Pharmacology · 10.11.2026
DOI: 10.1111/bph.70730 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 10.11.2026. Verfasst von Daniele Dall'Olio und 16 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart-Lung Foundation, Swedish Research Council, Region Stockholm City Council.
Abstract (Originalsprache)
Background and Purpose Multimodal integration of clinical and omics data could clarify the hepatic mechanisms of lipid‐lowering therapies, but interpretable methods for heterogeneous data remain limited. The objective was to apply interpretable multimodal networks (IMNs), a topology‐aware framework that condenses heterogeneous omics and clinical data into compact, cross‐modal modules, to characterize treatment‐specific hepatic responses to simvastatin and ezetimibe. Experimental Approach In the Stockholm Study, patients scheduled for cholecystectomy were randomized for 4 weeks to simvastatin, ezetimibe, their combination or placebo. We integrated liver transcriptomics and DNA methylation with plasma/bile biochemistry, including lipoprotein functionality, on the human protein–protein interactome to build treatment‐specific IMNs and evaluated selected network‐derived predictions in a human hepatocyte‐like model (SOAT2‐only‐HepG2). Key Results IMNs reduced dimensionality while preserving network topology, producing distinct molecular signatures for simvastatin, ezetimibe and combination therapy that mapped to different biological processes; the placebo network was less multimodal and more fragmented. IMNs highlighted apolipoprotein‐centred modules and predicted drug effects on APOA2, PPARA and PTPRS, linked to plasma C‐peptide. In SOAT2‐only‐HepG2 cells, selected predictions were supported experimentally, including APOA2 induction and ezetimibe‐associated PTPRS upregulation. Conclusions and Implications IMNs provide a practical, interactome‐based route from multimodal patient data to focused, testable hypotheses about lipid‐lowering therapies, yielding compact features suitable for downstream predictive modelling while retaining biological interpretability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
- Cardio Metabolic Unit, Department of Laboratory Medicine, and Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Medicine Unit of Endocrinology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Biochemistry, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
ORCID-Profile: Daniele Dall'Olio, Matteo Pedrelli, Claudia Sala, Francesca Grassi, Ruisheng Wang, Osman Ahmed, Carsten O Daub, Daniel Remondini, Gastone Castellani, Davide Gentilini, Chiara Pirazzini, Paolo Garagnani, Enrico Petrillo, Matteo Bersanelli, Elliott M Antman, Joseph Loscalzo, Paolo Parini
Förderung
- Swedish Heart-Lung Foundation
- Swedish Research Council
- Region Stockholm City Council
- Karolinska Institutet
- SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)
- Hjärt-Lungfonden
- Vetenskapsrådet
Zitieren
APA
Dall'Olio, D., Pedrelli, M., Sala, C., Grassi, F., Wang, R., Ahmed, O., Daub, C. O., Remondini, D., Castellani, G., Gentilini, D., Pirazzini, C., Garagnani, P., Petrillo, E., Bersanelli, M., Antman, E. M., Loscalzo, J., & Parini, P. (2026). Interpretable multimodal network analysis of lipid‐lowering therapies. British Journal of Pharmacology. https://doi.org/10.1111/bph.70730
Vancouver
Dall'Olio D, Pedrelli M, Sala C, Grassi F, Wang R, Ahmed O, et al. Interpretable multimodal network analysis of lipid‐lowering therapies. British Journal of Pharmacology. 2026. doi:10.1111/bph.70730
BibTeX
@article{DallOlio2026,
author = {Dall'Olio, Daniele and Pedrelli, Matteo and Sala, Claudia and Grassi, Francesca and Wang, Ruisheng and Ahmed, Osman and Daub, Carsten O and Remondini, Daniel and Castellani, Gastone and Gentilini, Davide and Pirazzini, Chiara and Garagnani, Paolo and Petrillo, Enrico and Bersanelli, Matteo and Antman, Elliott M and Loscalzo, Joseph and Parini, Paolo},
title = {Interpretable multimodal network analysis of lipid‐lowering therapies},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70730}
}
EUVIMED